Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
about
Cardiovascular impact of drugs used in the treatment of diabetesClinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.Cardiovascular safety profile of currently available diabetic drugs.Coronary artery disease and diabetes mellitus.Vildagliptin , a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin.Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus.
P2860
Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
@en
type
label
Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
@en
prefLabel
Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
@en
P2093
P2860
P1476
Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
@en
P2093
Jyoti Bhat
Ping H Wang
Samar Singh
P2860
P2888
P356
10.1007/S11886-012-0327-1
P577
2013-01-01T00:00:00Z
P6179
1013688371